ストックスクリーナーアプリを入手
1.25
4.58%
-0.06
アフターアワーズ：
1.25
前日終値:
$1.31
開ける：
$1.31
24時間の取引高:
8,370
Relative Volume:
0.26
時価総額：
$9.17M
収益：
$5.64M
当期純損益:
$-23.88M
株価収益率:
-2.3585
EPS:
-0.53
ネットキャッシュフロー:
$-22.36M
1週間 パフォーマンス:
-10.07%
1か月 パフォーマンス:
-14.38%
6か月 パフォーマンス:
-59.28%
1年 パフォーマンス:
-83.33%
1日の値動き範囲:
$1.25
$1.31
1週間の範囲:
$1.25
$1.41
52週間の値動き範囲:
$1.20
$8.996
Evogene Ltd Stock (EVGN) Company Profile
EVGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.25 | 9.17M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-10-08 | 開始されました | ROTH Capital | Buy |
| 2021-07-29 | 開始されました | Aegis Capital | Buy |
| 2020-12-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2013-12-16 | 開始されました | Oppenheimer | Outperform |
Evogene Ltd (EVGN) 最新ニュース
Evogene (NASDAQ:EVGN) Share Price Passes Below 200 Day Moving Average – What’s Next? - Defense World
StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split - Marketscreener.com
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene Announces Filing of Annual Report on Form 20-F - GuruFocus.com
AgPlenus Announces Discovery of a New Mode of Action for Fungici - GuruFocus.com
Evogene Ltd. Earnings Call: Growth Amid Challenges - TipRanks
Evogene Ltd. (NASDAQ:EVGN) Q4 2024 Earnings Call Transcript - Insider Monkey
Evogene price target lowered to $6 from $11.25 at Alliance Global Partners - TipRanks
Evogene: Q4 Earnings Snapshot - Barchart
Evogene Ltd to Host Earnings Call - ACCESS Newswire
Evogene Ltd. (NASDAQ:EVGN) Short Interest Up 22.1% in February - Defense World
Evogene Ltd (EVGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 - StreetInsider.com
Evogene Ltd. Reports Revenue Growth and Strategic Focus - TipRanks
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results - The Malaysian Reserve
Earnings call transcript: Evogene Q4 2024 beats EPS forecast, misses revenue - Investing.com
Evogene Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Evogene reports Q4 EPS 6c vs. ($1.30) last year - TipRanks
Evogene reports Q4 revenue miss, shares slip By Investing.com - Investing.com South Africa
Evogene reports Q4 revenue miss, shares slip - Investing.com
Evogene earnings beat by $0.66, revenue fell short of estimates - Investing.com India
SEC Form 424B3 filed by Evogene Ltd - Quantisnow
Evogene (TSE:EVGN) Given New C$3.00 Price Target at Desjardins - Defense World
Evogene Ltd expected to post a loss of 72 cents a shareEarnings Preview - TradingView
Evogene (NASDAQ:EVGN) Now Covered by StockNews.com - Defense World
Evogene Ltd. to Host Earnings Call - ACCESS Newswire
Evogene (EVGN) Projected to Post Quarterly Earnings on Thursday - Defense World
Evogene Schedules Fourth Quarter 2024 Financial Results Release - Krishak Jagat English
Evogene Sets Date for Q4 Earnings: Key Details for Your Calendar - Stock Titan
AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease - Nasdaq
Revolutionary Discovery: New Weapon Against €1.2B Wheat Disease Threat Unveiled - Stock Titan
Evogene Shareholders Approve Key Proposal in Special Meeting - TipRanks
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - Armenian Reporter
Evogene Ltd. Reschedules Special General Meeting Due to Lack of Quorum - TipRanks
Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com - Defense World
United States Agricultural Biologicals Market Competition - GlobeNewswire
United States Agricultural Biologicals Market Competition and Forecasts 2024-2029, Competitive Analysis of BASF, Syngenta Crop Protection, Bayer, Evogene ,Vegalab Inc. - Yahoo Finance
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - GuruFocus.com
Monsanto Expands Agreement with Israel’s Evogene - Agribusiness Global
Higher R&D costs lead Evogene to loss - גלובס
Evogene Ltd. Announces Conclusion of Employment of Eyal Ronen as Executive Vice President of Business Development, Effective March 4, 2025 - Marketscreener.com
Evogene Announces Management Restructuring - TipRanks
Evogene Ltd (EVGN) 財務データ
収益
当期純利益
現金流量
EPS
1.05%
1.79%
大文字化:
|
ボリューム (24 時間):